Court Ruling Blocks Companies from Importing Gilead Medications, Threatening AFP Health Programs A recent court decision has sent shockwaves through the alternative funding programs (AFPs) industry, which imports medications from overseas to circumvent high prescription drug prices.
The ruling upholds a preliminary injunction against several companies that import Gilead's HIV medication Biktarvy from Turkey without proper FDA oversight.
The court's decision is a victory for Gilead Sciences, but it raises concerns about the consequences for patients who rely on AFPs.